Dave Weiner

Stock Analyst at Piper Sandler

(1.18)
# 1428
Out of 5,291 analysts
7
Total ratings
50.00%
Success rate
22.30%
Average return
2 Stocks
Name Action Price Target Current % Upside Ratings Updated
Myriad Genetics
Upgrades: Overweight
12 13
8.79 42.21% 2 Mar 12, 2025
Lululemon Athletica
Upgrades: Buy
58 0
n/a n/a 5 Dec 14, 2017